According to a new report Europe Biosensors Market, published by KBV research, the Europe Biosensors Market would witness market growth of 7.8% CAGR during the forecast period (2019-2025).
The Germany market dominated the Europe Piezoelectric Biosensors Market by Country 2018, growing at a CAGR of 5.9 % during the forecast period. The UK market is expected to witness a CAGR of 6.3% during (2019-2025). Additionally, The France market is expected to witness a CAGR of 7.9% during (2019-2025).
The Blood Glucose Monitoring market dominated the Europe Biosensors Market by Medical Applications Type 2018, growing at a CAGR of 5.7 % during the forecast period. The Cholesterol Testing market is expected to witness a CAGR of 6.4% during (2019-2025). The Pregnancy Testing market is expected to witness a CAGR of 8.2% during (2019-2025). Additionally, The Blood Gas Analyzer market is expected to witness highest CAGR of 8.8% during (2019-2025).
The Non-wearable market dominated the France Biosensors Market by Product 2018, thereby, achieving a market value of $1,012.4 million by 2025, growing at a CAGR of 7.8 % during the forecast period. The Wearable market is expected to witness a CAGR of 13.3% during (2019-2025).
Full Report: https://www.kbvresearch.com/europe-biosensors-market/
The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Danaher Corporation, ABBOTT Laboratories, Siemens AG, AgaMatrix, Inc., BAYER AG, Johnson and Johnson, LIFESENSORS, Inc., Medtronic Plc., Bio-Rad laboratories, Inc. and Analog Devices, Inc.
By Product
By Technology
By End User
By Application
By Country
Companies Profiled
Unique Offerings from KBV Research
Unique Offerings 
